[1]
|
Whiteford, H.A., Degenhardt, L., Rehm, J., et al. (2010) Global Burden of Disease Attributable to Mental and Substance Use Disorders: Findings from the Global Burden of Disease Study. The Lancet, 382, 1575-1586.
https://doi.org/10.1016/S0140-6736(13)61611-6
|
[2]
|
Hu, H.R., Hu, C.Y., Ren, Z.H., et al. (2020) Trends in the Incidence and DALYs of Bipolar Disorder at Global, Regional, and National Levels: Results from the Global Burden of Disease Study 2017. Journal of Psychiatric Research, 125, 96-105. https://doi.org/10.1016/j.jpsychires.2020.03.015
|
[3]
|
Zutshi, A., Eckert, K.A., Hawthorne, G., et al. (2011) Changes in the Prevalence of Bipolar Disorders between 1998 and 2008 in an Australian Population. Bipolar Disorder, 13, 182-188.
https://doi.org/10.1111/j.1399-5618.2011.00907.x
|
[4]
|
Clemente, A.S., Diniz, B.S., Nicolato, R., et al. (2015) Bi-polar Disorder Prevalence: A Systematic Review and Meta-Analysis of the Literature. Brazilian Journal of Psychiatry, 37, 155-161.
https://doi.org/10.1590/1516-4446-2012-1693
|
[5]
|
Kessing, L.V., González-Pinto, A., Fagiolini, A., et al. (2021) DSM-5 and ICD-11 Criteria for Bipolar Disorder: Implications for the Prevalence of Bipolar Disorder and Validity of the Diagnosis—A Narrative Review from the ECNP Bipolar Disorders Network. European Neuropsychopharmacology, 47, 54-61.
https://doi.org/10.1016/j.euroneuro.2021.01.097
|
[6]
|
Mezes, B., Lobban, F., Deborah, C.D., et al. (2022) Recov-ery beyond Clinical Improvement—Recovery Outcomes Measured for People with Bipolar Disorder between 1980 and 2020. Journal of Affective Disorders, 309, 375-392.
https://doi.org/10.1016/j.jad.2022.04.075
|
[7]
|
Vieta, E., Salagre, E., Grande, I., et al. (2018) Early Intervention in Bipolar Disorder. American Journal of Psychiatry, 175, 411-426. https://doi.org/10.1176/appi.ajp.2017.17090972
|
[8]
|
Carvalho, A.F., Firth, J. and Vieta, E. (2020) Bipolar Disor-der. The New England Journal of Medicine, 383, 58-66.
https://doi.org/10.1056/NEJMra1906193
|
[9]
|
Robles, A.I., Yang, P., Jen, J., McClary, A.C., et al. (2014) A DRD1 Polymorphism Predisposes to Lung Cancer among Those Exposed to Secondhand Smoke during Childhood. Cancer Prevention Research (Phila), 7, 1210-1218.
https://doi.org/10.1158/1940-6207.CAPR-14-0158
|
[10]
|
Kishi, T., Ikuta, T., Matsuda, Y., et al. (2022) Pharmaco-logical Treatment for Bipolar Mania: A Systematic Review and Network Meta-Analysis of Double-Blind Randomized Controlled Trials. Molecular Psychiatry, 27, 1136-1144.
https://doi.org/10.1038/s41380-021-01334-4
|
[11]
|
Yao, J., Ding, M., Xing, J., et al. (2014) Genetic Association between the Dopamine D1-Receptor Gene and Paranoid Schizophrenia in a Northern Han Chinese Population. Neuro-psychiatric Disease and Treatment, 10, 645-652.
https://doi.org/10.2147/NDT.S61227
|
[12]
|
Elinsky, G.S., Sirois, C.L., Rich, M.T., et al. (2013) Dopamine Recep-tors in Human Embryonic Stem Cell Neurodifferentiation. Stem Cells and Development, 22, 1522-1540. https://doi.org/10.1089/scd.2012.0150
|
[13]
|
Lee, S.H., Kim, Y.M., Yajima, S., et al. (2003) Genomic Organization and Promoter Characterization of the Murine Dopamine Receptor Regulating Factor (DRRF) Gene. Gene, 304, 193-199.
https://doi.org/10.1016/S0378-1119(02)01209-X
|
[14]
|
Kim, O.S., Kim, H.J. and Kwak, H.J. (2003) Human Act and AR1 Sequences Differentially Regulate Murine and Human D1A Dopamine Receptor Promoters. Molecules and Cells, 15, 294-300.
|
[15]
|
Cipolletta, E., Ciccarelli, M., Izzo, R., et al. (2012) A Polymorphism within the Promoter of the Dopamine Receptor D1 (DRD1-48A/G) Associates with Impaired Kidney Function in White Hypertensive Patients. Translational Medicine @ UniSa, 2, 10-19.
|
[16]
|
Pan, Y., Yao, J. and Wang, B. (2014) Association of Dopamine D1 Receptor Gene Polymorphism with Schizophrenia: A Meta-Analysis. Neuropsychiatric Disease and Treatment, 10, 1133-1139. https://doi.org/10.2147/NDT.S63776
|
[17]
|
Dmitrzak-Weglarz, M., Rybakowski, J.K. and Slopien, A. (2006) Dopamine Receptor D1 Gene-48A/G Polymorphism Is Associated with Bipolar Illness but Not with Schizophre-nia in a Polish Population. Neuropsychobiology, 53, 46-50.
https://doi.org/10.1159/000090703
|
[18]
|
Bocchetta, A. and Traccis, F. (2017) The Sardinian Puzzle: Concentration of Major Psychoses and Suicide in the Same Sub-Regions across One Century. Clinical Practice and Epidemiology in Mental Health, 13, 246-254.
https://doi.org/10.2174/1745017901713010246
|
[19]
|
Dmitrzak-Weglarz, M., Szczepankiewicz, A., Rybakowski, J., et al. (2021) Expression Biomarkers of Pharmacological Treatment Outcomes in Women with Unipolar and Bipolar De-pression. Pharmacopsychiatry, 54, 261-268.
https://doi.org/10.1055/a-1546-9483
|
[20]
|
Zhao, L.S., Lin, Y., Lao, G.H., et al. (2015) Association Study of Dopa-mine Receptor Genes Polymorphism with Cognitive Functions in Bipolar I Disorder Patients. Journal of Affective Disor-ders, 170, 85-90.
https://doi.org/10.1016/j.jad.2014.08.039
|
[21]
|
Zhang, C., Wu, Z.G., Shao, Y., et al. (2011) Association Analysis between Dopamine D1 Receptor Gene and Symptom Quantitative Trait of Schizophrenia. Chinese Medical Journal, 91, 2019-2022.
|
[22]
|
Niu, Y.M., Zhang, J. and Tang, H. (2023) Association between DRD2/ANKK1 rs1800497 C > T Polymorphism and Post-Traumatic Stress Disorder Susceptibility: A Multivariate Meta-Analysis. Frontiers in Neurosci-ence, 17, Article ID: 1102573. https://doi.org/10.3389/fnins.2023.1102573
|
[23]
|
Daza-Hernández, S., Pérez-Luque, E. and Martínez-Cordero, C. (2023) Analysis of Factors Associated with Outcomes of Bariatric Surgery: rs1800497 ANKK1, rs1799732 DRD2 Genetic Polymorphisms, Eating Behavior, Hedonic Hunger, and Depressive Symptoms. Journal of Gastrointestinal Surgery. https://doi.org/10.1007/s11605-023-05699-5
|
[24]
|
Qin, Y., Sun, Q. and Wang, L. (2023) DRD2 TaqIA Polymorphism-Related Functional Connectivity between Anterior Insula and Dorsolateral Pre-frontal Cortex Predicts the Retention Time in Heroin-Dependent Individuals under Methadone Maintenance Treatment. European Archives of Psychiatry and Clinical Neuroscience.
https://doi.org/10.1007/s00406-023-01626-6
|
[25]
|
Zou, Y.F., Wang, F., Feng, X.L., et al. (2012) Association of DRD2 Gene Polymorphisms with Mood Disorders: A Meta-Analysis. Journal of Affective Disorders, 136, 229-237. https://doi.org/10.1016/j.jad.2010.11.012
|
[26]
|
张明, 张钊, 魏之昀, 等. 多巴胺D2受体基因与精神分裂症和双相情感障碍关联研究的荟萃分析[J]. 国际遗传学杂志, 2010, 33(1): 5-11. https://doi.org/10.3760/cma.j.issn.1673-4386.2010.01.002
|
[27]
|
张沛文, 邹韶红. 儿童青少年双相障碍冲动攻击行为相关基因研究进展[J]. 国际精神病学杂志, 2020, 47(6): 1099-1101. https://doi.org/10.13479/j.cnki.jip.2020.06.004
|
[28]
|
Del Casale, A., Paolini, M., Gentile, G., et al. (2022) Dopa-mine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Men-tal Disorders. Journal of Personalized Medicine, 12, 565.
https://doi.org/10.3390/jpm12040565
|
[29]
|
Peciña, M., Sikora, M. and Avery, E.T. (2017) Striatal Dopamine D2/3 Receptor-Mediated Neurotransmission in Major Depression: Implications for Anhedonia, Anxiety and Treatment Re-sponse. European Neuropsychopharmacology, 27, 977-986. https://doi.org/10.1016/j.euroneuro.2017.08.427
|
[30]
|
Park, C.I., Kim, H.W., Hwang, S.S., et al. (2021) Influence of Dopamine-Related Genes on Craving, Impulsivity, and Aggressiveness in Korean Males with Alcohol Use Disorder. European Archives of Psychiatry and Clinical Neuroscience, 271, 865-872. https://doi.org/10.1007/s00406-019-01072-3
|
[31]
|
Chang, T.T., Chen, S.L. and Chang, Y.H. (2016) The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients with Bipolar II Disorder. Medicine (Balti-more), 95, e3488.
https://doi.org/10.1097/MD.0000000000003488
|
[32]
|
胡伟, 邹韶红, 佟钙玉, 等. 双相情感障碍冲动攻击行为相关基因研究进展[J]. 国际精神病学杂志, 2018, 45(5): 781-784. https://doi.org/10.13479/j.cnki.jip.2018.05.005
|
[33]
|
王燕. DRD4基因rs752306多态性与蒙古族学龄儿童攻击行为的相关性研究[J]. 绿色科技, 2018(1): 220-223.
|
[34]
|
Nguyen, T.M.L., Jollant, F., Tritschler, L., et al. (2023) Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impul-sivity: A Narrative Review. Pharmaceuticals (Basel), 16, Article No. 634. https://doi.org/10.3390/ph16040634
|
[35]
|
Tunbridge, E.M., Narajos, M. and Harrison, C.H. (2019) Which Dopa-mine Polymorphisms Are Functional? Systematic Review and Meta-Analysis of COMT, DAT, DBH, DDC, DRD1-5, MAOA, MAOB, TH, VMAT1, and VMAT2. Biological Psychiatry, 86, 608-620. https://doi.org/10.1016/j.biopsych.2019.05.014
|
[36]
|
Maingret, F. and Groc, L. (2021) Characterization of the Func-tional Cross-Talk between Surface GABAA and Dopamine D5 Receptors. International Journal of Molecular Sciences, 22, Article No. 4867.
https://doi.org/10.3390/ijms22094867
|
[37]
|
Amare, A.T., Schubert, K.O. and Baune, B.T. (2017) Phar-macogenomics in the Treatment of Mood Disorders: Strategies and Opportunities for Personalized Psychiatry. EPMA Journal, 8, 211-227.
https://doi.org/10.1007/s13167-017-0112-8
|
[38]
|
van der Burg, N.C., Al Hadithy, A.F.Y., van Harten, P.N., et al. (2020) The Genetics of Drug-Related Movement Disorders, an Umbrella Review of Meta-Analyses. Molecular Psychia-try, 25, 2237-2250.
https://doi.org/10.1038/s41380-020-0660-5
|
[39]
|
Juza, R., Stefkova, K. and Dehaen, W. (2021) Synthesis and in Vitro Evaluation of Novel Dopamine Receptor D2 3,4-Dihydroquinolin-2(1H)-One Derivatives Related to Aripiprazole. Biomolecules, 11, Article No. 1262.
https://doi.org/10.3390/biom11091262
|
[40]
|
Blacker, C.J., Lewis, C.P. and Frye, M.A. (2017) Metabotropic Glu-tamate Receptors as Emerging Research Targets in Bipolar Disorder. Psychiatry Research, 257, 327-337. https://doi.org/10.1016/j.psychres.2017.07.059
|